Literature DB >> 7862936

The relationship between motor effects in rats following acute and chronic haloperidol treatment.

H A Jørgensen1, O A Andreassen, K Hole.   

Abstract

Tardive dyskinesia (TD) is a serious and sometimes irreversible side-effect to long-term neuroleptic treatment. In order to find predictors for development of TD, it would be of interest to known whether susceptibility to develop acute side-effects increases the risk of TD development. The study investigated in female Sprague-Dawley rats the relationship between haloperidol-induced acute motor effects, assessed by means of the grid test and the open field test, and the chronic motor effect assessed as vacuous chewing movements (VCM). The doses of haloperidol were 1.2, 2.4 and 4.8 mg/kg IP in the acute experiments and haloperidol decanoate 38 mg/kg per 4 weeks IM in the chronic experiment. The VCM obtained at different timepoints during the 24 weeks of chronic treatment were highly correlated. However, no correlation was found between the motor effects in the acute and the chronic experiments. The study does not indicate any connection between susceptibility to acute side-effects on neuroleptics and later development of TD.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7862936     DOI: 10.1007/bf02244876

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  16 in total

1.  Pseudoparkinsonism and tardive dyskinesia.

Authors:  G E Crane
Journal:  Arch Neurol       Date:  1972-11

2.  Incidence of tardive dyskinesia: five-year data from a prospective study.

Authors:  J M Kane; M Woerner; P Weinhold; J Wegner; B Kinon; M Borenstein
Journal:  Psychopharmacol Bull       Date:  1984

3.  Changes in dopamine-mediated behaviour during one year's neuroleptic administration.

Authors:  A Clow; P Jenner; C D Marsden
Journal:  Eur J Pharmacol       Date:  1979-08-15       Impact factor: 4.432

4.  Difference in catalepsy response in inbred rats during chronic haloperidol treatment is not predictive of the intensity of behavioral hypersensitivity which subsequently develops.

Authors:  B J Kinon; J M Kane
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Oral dyskinesia in rats following brain lesions and neuroleptic drug administration.

Authors:  L M Gunne; J Growdon; B Glaeser
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

6.  Persistent tardive dyskinesia: demographic and pharmacological risk factors.

Authors:  G Muscettola; S Pampallona; G Barbato; M Casiello; P Bollini
Journal:  Acta Psychiatr Scand       Date:  1993-01       Impact factor: 6.392

7.  Tardive dyskinesia: a 3-year follow-up study.

Authors:  T R Barnes; T Kidger; S M Gore
Journal:  Psychol Med       Date:  1983-02       Impact factor: 7.723

8.  Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment.

Authors:  J L Waddington; A J Cross; S J Gamble; R C Bourne
Journal:  Science       Date:  1983-04-29       Impact factor: 47.728

9.  Spontaneous chewing movements in rats during acute and chronic antipsychotic drug administration.

Authors:  L M Gunne; U Andersson; U Bondesson; P Johansson
Journal:  Pharmacol Biochem Behav       Date:  1986-10       Impact factor: 3.533

10.  Involvement of extrapyramidal motor mechanisms in the suppression of locomotor activity by antipsychotic drugs: a comparison between the effects produced by pre- and post-synaptic inhibition of dopaminergic neurotransmission.

Authors:  S Ahlenius; V Hillegaart
Journal:  Pharmacol Biochem Behav       Date:  1986-05       Impact factor: 3.533

View more
  4 in total

1.  Relationship of orofacial movements to behavioural repertoire as assessed topographically over the course of 6-month haloperidol treatment followed by 4-month withdrawal.

Authors:  Ian E J De Souza; Niamh M Dawson; Jeremiah J Clifford; John L Waddington; Gloria E Meredith
Journal:  Psychopharmacology (Berl)       Date:  2003-06-27       Impact factor: 4.530

2.  GM1 ganglioside attenuates the development of vacuous chewing movements induced by long-term haloperidol treatment of rats.

Authors:  O A Andreassen; H A Jørgensen
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

3.  Correlation of vacuous chewing movements with morphological changes in rats following 1-year treatment with haloperidol.

Authors:  C K Meshul; O A Andreassen; C Allen; H A Jørgensen
Journal:  Psychopharmacology (Berl)       Date:  1996-06       Impact factor: 4.530

4.  The mitochondrial toxin 3-nitropropionic acid induces vacuous chewing movements in rats. Implications for tardive dyskinesia?

Authors:  O A Andreassen; H A Jørgensen
Journal:  Psychopharmacology (Berl)       Date:  1995-06       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.